
UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.
Comparing neural correlates of consciousness: from psychedelics to hypnosis and meditation
Overall, these results extend our understanding of the mechanisms of action of ASC and highlight the importance of exploring how these effects can be leveraged in the treatment of psychiatric disorders.
Abstracts of the 31st European Congress of Psychiatry
Abstracts of the 31st European Congress of Psychiatry
How to navigate sex on Molly: We asked sex therapists about the good, the bad - and the cuddly
Sex on molly is not something to jump into hastily without preparation.
Reducing the harms of nonclinical psychedelics use through a peer-support telephone helpline
The data suggest that access to a psychedelic helpline surrounding psychedelic experiences may avert harmful outcomes and offset the burden on emergency and medical services.
Psychologists' and psychotherapists' knowledge, attitudes, and clinical practices regarding the therapeutic use of psychedelics
This study explored the current knowledge, attitudes, and clinical practices regarding psychedelics among mental health professionals in California,
Must psilocybin always “assist psychotherapy”?
The statement that the drug is a catalyst for treatment, not a treatment in itself, is grounded in an odd dualism.
A systematic review on the therapeutic effects of ayahuasca
To the best of our knowledge, this is the first systematic review where all the findings of therapeutic effects associated with the consumption of ayahuasca are reviewed.
Extended difficulties following the use of psychedelic drugs: A mixed methods study
The long-term adverse effects of psychedelic use, which can persist for weeks, months, or even years, is a significant but relatively unexplored area in psychedelic research.
The impact of psilocybin on patients experiencing psychiatric symptoms: A systematic review of randomized clinical trials
RCTs show the efficacy of psilocybin in the treatment of anxiety and depression symptoms, as well as improvement in HRQoL, and no serious side effects.
Psychedelics may reopen locked learning opportunities
This research suggests that psychedelics “are the master key for unlocking lots of different critical periods.”
A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression
Administration of GH001 to a cohort of 16 patients with TRD was well tolerated and provided potent and ultra-rapid antidepressant effects.
Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth
Ketamine was associated with comparable clinical benefits, safety, and tolerability in a TAY sample as compared to a matched GA TRD sample.
Unlocking the self: Can microdosing psychedelics make one feel more authentic?
We propose that feeling and behaving authentically could have a central role in explaining the positive effects of microdosing on health and wellbeing that are reported by current research.
In naturalistic psychedelic use, group use is common and acceptable
Naturalistic psychedelic users are as likely to report an overall positive outcome and no more likely to report adverse events in group settings than in solo settings. This supports further research into PAP in group settings.
Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms
We summarize preliminary data on the efficacy of psychedelic-assisted therapy in people with anorexia nervosa, bulimia nervosa, and binge eating disorder,.
Psychedelics reopen the social reward learning critical period
Notably, the time course of critical period reopening is proportional to the duration of acute subjective effects reported in humans.
Effects of ayahuasca on gratitude and relationships with nature: An open-label, naturalistic study
There was a significant increase in gratitude, nature relatedness, and nature appreciation at the one-week and one-month follow-ups compared to baseline.